Please login to the form below

Not currently logged in

Bridge Biotherapeutics

This page shows the latest Bridge Biotherapeutics news and features for those working in and with pharma, biotech and healthcare.

FDA clears wider use for Boehringer’s Ofev in lung disease

FDA clears wider use for Boehringer’s Ofev in lung disease

followed earlier deals with Bridge Biotherapeutics for an Ofev follow-up and Yuhan focusing on lover fibrosis.

Latest news

More from news
Approximately 1 fully matching, plus 4 partially matching documents found.

Subscribe to our email news alerts


Add my company
Oxford University Press

Oxford University Press publishes over 100 prestigious, highly cited, and authoritative medical journals, many in collaboration with some of the...

Latest intelligence

New Playbook Alert: Virtual Patient Engagement
Millennials: the wellness generation
Looking at the results from a global healthcare research study focusing on the patients of the future...
The problem with clinical trials (and how virtual insight-gathering can help)
While still the gold standard of research, clinical trials are often riddled with issues that limit their applicability to broader populations or delay market access....